Epilepsy is described as the most common chronic brain disorder. A typical symptom of epilepsy results in uncontrolled convulsions caused by temporary excessive neuronal discharges. Although several new anticonvulsants have been introduced, some types of seizures have still not been adequately controlled with these new and current therapies. There is an urgent need to develop new anticonvulsant drugs to control the many different types of seizures. Many studies have shown that the epilepsies involve more than one mechanism and therefore may be responsible for the various types of observed seizures. Recently reported studies have shown that a group of newly synthesized 6 Hz active anticonvulsant fluorinated N-benzamide enaminones exhibited selective inhibitions of voltage-gated sodium (Na v ) channels. Na v channels are responsible for the initial inward currents during the depolarization phases of the action potential in excitable cells. The activation and opening of Na v channels result in the initial phases of action potentials. We hypothesize that there is an essential pharmacophore model for the interactions between these enaminones and the active sites of Na v channels. The research reported here is focused on molecular docking studies of the interactions that occur between the fluorinated N-benzamide enaminones and the Na v channels. These studies may open an avenue for designing anticonvulsant drugs by inhibiting Na v channels.
Introduction
Epilepsy is one of the most frequent neurological abnormalities which affect people of all ages. Currently, an estimated 65 million people worldwide live with epilepsy and close to 80% of them live in low-to middle-income countries. Seventy percent (70%) of epilepsy patients could live a quality life without seizures, if more sufficient and efficient diagnoses and treatments were made available to them. However, the costs associated with uncontrolled seizures are seven times higher than the average of all chronic diseases [1] . In the United States alone, the health care costs associated with epilepsy are approximately $15.5 billion per
year. The burden of epilepsy worldwide is huge; and the need for safer and more effective anticonvulsant drugs is paramount in order to decrease costs for the treatment of epilepsy [2] .
Over the years, numerous efforts have been dedicated towards the discovery of new, safe and effective drugs for treating epilepsy. There are several different types of seizures. Most seizures can be categorized as either focal or generalized.
Although several new anticonvulsants have been introduced, they are primarily focused on focal seizures. For some types of seizures, such as absence seizure and clonic seizures of generalized seizures, they still have not been adequately controlled with many of these newer and current therapies [3] . Epilepsy is characterized by uncontrolled convulsions and has been known to be caused by excessive temporary neuronal discharges. In view of the broad etiology of the syndrome, much evidence appears to suggest that there is more than one mechanism responsible for the various seizures. Therefore, the need for different therapeutic agents is to be expected. It has been shown that the voltage-gated sodium (Na v ) channels are responsible for the initial inward current during the depolarization phase of the action potential in excitable cells [4] [5] [6] . The voltage-gated sodium (Na v ) channels are also associated with the reduction of GAB Aergic transmission and excessive glutamatergic neurotransmission which can result in various prominent physiological abnormalities that can lead to the triggering of epileptic seizures [4] [5] [6] .
A number of structurally diverse anticonvulsant active enaminone analogues have been synthesized and studied in our laboratory for over two decades. These compounds have displayed a wide range of structural diversity with good to moderate protection against the maximal electroshock seizure (MES) test and the subcutaneous pentylenetetrazol (ScPTZ) test. The enaminone analogues with the central part of (-HN-C=C-C=O) have been found to share common pharmacophore for their anticonvulsant activities. A reliable 3D QSAR model has been generated by using ligand-based CoMFA and CoMSIA analyses. This model has been used to predict specific structural and electronic futures which is essential in studying active enaminones and their interactions with potential targets [7] - [13] . The initial results from organic synthesis, biological activity tests and ligand-based 3D QSAR studies have shown promise in the development of new anticonvulsant drugs utilizing various enaminones. However, neither the Open Journal of Physical Chemistry mechanism of the anticonvulsant activities nor the molecular target(s) of these active enaminones have been fully determined or known. There is some evidence that the anticonvulsant activities of these enaminones appear to act through two modes of action: inhibition of sodium channels and via a GAB Aergic pathway [7] [8] . Recent electrophysiology studies have shown that some of a group of newly synthesized 6 Hz active anticonvulsant fluorinated N-benzamide enaminone analogs exhibit inhibition of Na v channels [14] . We hypothesize that there is an essential pharmacophore model that best describes the interactions whichoccur between enaminones with active binding site(s) of Na v channels. In other words, there appears to be a common mechanism by which the interactions between anticonvulsant enaminones and target Na v channels occur. It may be that these enaminones interact with Na v channels in the same binding site(s) and in a similar manner.
Na v channels are responsible for the initial inward current during the depolarization phase of the action potential in excitable cells [4] [6] . The activation and opening of sodium channel(s) could result in the initial phase of an action potential. There is great interest in gaining a better understanding of the structure and function relationship of Na v channels. However, full-length structures of eukaryotic Na v channels are hard to obtain, even in low resolution, because of their long and pseudo-repeating nature. In 2017, a complete crystal structure of an open form of Na v channels has been determined at high resolution [15] . The crystal structure of a complete Na v sodium channel in a full open conformation is derived from a prokaryote [15] . Sequence alignments of eukaryotic Na v channels and prokaryotic Na v channels have been shown to share only 18% to 28% sequence identity [16] . However, some bacterial Na v channels have shown similar functions or responses as that of human Na v channels. As an example of similar function or response between bacterial and human Na v channels, both have been shown to be blocked by human Na v channel blockers [16] [17] . Even though the sequence identities are lower than 30%, it appears that function(s) of Table 1 Table 1 have been found to exhibit relatively stronger inhibition of Na v channels [14] .
Data Setting

Ligand Fluorinated N-Benzamide Enaminones
Target Protein Nav Channel
The target protein used for the molecular docking studies described here, is a te- [19] . This high resolution, full-length crystal structure of the Na v channel served as a solid basis for studying interactions between Na v channels and its inhibitor enaminones.
Molecular Docking
Binding Sites Discovery
The possible active binding sites in the target tetrameric protein Na v channel were identified by the Site Finder module built in MOE. The Site Finder module utilizes alpha-shape and discrete-flow methods developed by Edelsbrunner, et al.
[20] [21] . This Site Finder module scores and visualizes individual sites by populating them with dummy atoms which serve as probes denoting zones of tight atom packing available for ligand docking. The collection of dummy atoms, which is also called alpha centers or alpha spheres, are classified as either "hydrophobic" or "hydrophilic". This is dependent upon the region of sphere being occupied in the receptor is preferred by what type of the atoms in the pocket [22] . The hydrophilic alpha sphere represents a spot most useful in the formation of hydrogen bonds and the hydrophobic alpha sphere represents a spot that is involved in hydrophobic interactions. After all binding pockets were identified, the Site Finder module ranked the pockets with their Propensity for Ligand Binding (PLB) score. The PLB score is based upon the amino acid composition of the pocket. The binding pockets can also be ranked by size, which is defined by the number of alpha spheres comprising the pocket(s).
Docking Procedure
The docking procedure employed the standard protocol as implemented in MOE 2018.0101 [18] . To perform docking studies, the ligand enaminones were built by using the Builder module in MOE with energy minimization and stored in the MDB format file. The target protein in this study is the tetrameric Na 
Results and Discussion
Na v channels are responsible for the initial inward currents during depolarization phases of the action potential in excitable cells. With the activation and opening of Na v channels resulting in the initial phase of the action potential, Na v channels play essential roles in excitable tissues [15] . Molecular docking studies were performed using the full-length open-form sodium channel complexed with ligand enaminones, in order to gain a better understanding of the mechanisms associated with Na v channel inhibition by fluorinated N-benzamide enaminones. Additionally, a comparative examination of common interaction characteristics between ligand enaminones and target Na v channels will also be derived from these molecular docking studies.
Structures of Ligand Enaminones
The newly synthesized 6 Hz active anticonvulsant fluorinated N-benzamide enaminones were built using the Builder module in MOE and individually energy minimized with an MMFF94x force field. They were then saved to the MDB format files and subsequently docked into selected possible binding pockets in the molecular docking studies reported here.
Structure of the Tetrameric Nav Channel
The structure of the Na v channel was taken from the Protein Data Bank (PDB id: 5 HVX). Figure 1 reveals that, the full-length open-form sodium channel is a tetramer with four repeating domains or chains. This structure was obtained by using the biomolecule assembly function of the PDB data bank. Figure 1(a) shows a side view of the tetrameric Na v channel that is colored to denote the four individual chains; which show the transmembrane pore domains on top and the alpha helical C terminal domains located under the pore gate. The structure in its fully activated state, with the outward gating charge position is exposed to the 
Putative Binding Pocket Discovery
The MOE binding site analysis described in methods and materials, identified a total of 55 possible binding sites or pockets in the target protein (tetrameric Na v channel). Figure 2(a) shows the 55 binding pockets populated with alpha spheres, which are sprayed over the entire target protein. Alpha spheres correspond to regions of the pocket in which the atoms are preferably associated with hydrophilic (red) or hydrophobic (grey) regions of the pocket. The size of a binding pocket is defined by the number of alpha spheres contained within the pocket. Since there were no constraints placed on pocket size during the Site Find procedure, the sizes of the 55 pockets varied from 8 alpha spheres to 340 alpha spheres. Upon inhibition(s) by enaminones of the Na v channels [14] , a Open Journal of Physical Chemistry Supplemental Table S1 . Table 2 and Supplemental Table S1 reveal that every ligand gets its top score when docked into pockets 2, 3, 4 and 5. This analysis indicates that pockets 2 through 5 strongly appear to be the preferred binding pockets for all 17 anticonvulsant enaminones cited in this study. Since Site Finder procedures were carried out on the tetrameric Na v channel prior to the docking procedure, the four pockets used for the docking procedures with each ligand were the same.
Further investigation found that these four pockets are located in between the chains of the tetramer. In addition, they are identical in size and composition.
Each of the four pockets were populated with 88 alpha spheres and comprised of the same group of residues from each of the two chains, between which the pocket is located. Table 3 lists the nine residues and the other six residues from the two chains, respectively. The six hydrophilic spheres are found outward of the gating charge position which is exposed to the extracellular surface. The solid surfaces represent lipophilicity of the binding pocket with hydrophilic highlighted in green and lipophilic highlighted in purple regions, respectively. Figure 3(c) shows the contact residues along with the local backbone and secondary structure of pocket 3. These contact residues were consistently found in pockets 2, 4 and 5 as well as 3.
Post Docking Analysis
In order to evaluate the possible mechanism(s) of the interactions which may occur between the anticonvulsant enaminones and target Na v channel, post docking analyses were carried out via the superimposition of all 17 anticonvulsant enaminones docked in pocket 3.
First, post docking analyses were carried out by examining the top scoring poses of all 17 anticonvulsant enaminones when docked in pocket 3. Figure 4(a) shows the superimposition of all 17 anticonvulsant enaminones docked in pocket 3. The 16 ligands were found to be deeply bound in the pocket with their structural cores (the cyclic enaminone moiety and benzene ring) fully buried inside. In addition, as indicated by the arrow, Figure 4 (a) also shows that ligand IAA61 binds in the pocket differently. By its top scoring pose, the benzene ring of ligand IAA61 extends out of the pocket. Figure 4(b) shows another angle of pocket 3 populated with alpha spheres, which indicates that the binding pocket is a long and narrow groove. Within this long and narrow groove the preferred hydrophobic atoms are packed in the middle and towards the C-terminal domain, while the hydrophilic atoms are located on the side towards the gating charge position that is exposed to the extracellular surface. Figure 4 Figure 5 shows the comparison of binding scores of all ligands docked in pocket 3. The binding score of different ligands varies. In this study, the binding score is the free energy of binding calculated by the London dG scoring function. A ligand with lower free energy of binding would be more favorable by atoms in the pocket. Figure 5 shows the free energy of binding in the pocket for ligand IAA69 is −6.0597 and has the lowest free energy of binding among the 17 ligands in this study. Therefore, ligand IAA69 is the most favored ligand for pocket 3. The free energy of binding in pocket 3 for ligand IAA61 is −5.574, indicating that it would be less favorable for binding in pocket 3 when compared to ligand IAA69. Figure 6 shows the structural comparison of the binding complex of ligands IAA 69 and IAA 61 in pocket 3. As shown in Figure 5 , ligand IAA69 has the lowest free energy of binding among the group, indicating that ligand IAA69 could be more favorable for binding in pocket 3 than other ligands. Figure 6(a) shows a close-up view of ligand IAA69 docked in pocket 3. In the circle highlighted blue in Figure 6 contrast, the binding score of ligand IAA61 appears to be less favorable for binding in pocket 3 than that of ligand IAA69. Figure 6 (c) shows that ligand IAA61 does not dock deeply in the bottom of pocket 3. Its benzene ring is contained on the top of the pocket. In addition, as shown within the blue circle of Figure 6(d) , the hydrophobic structural core of the ligand is away from the guide/(path) of the hydrophobic alpha spheres. The chemical structure of ligand IAA61 reveals that the benzene ring is monosubstituted with a trifluoromethyl group at the ortho position. The trifluoromethyl group in the ortho position is too bulky to block the free rotations of the substitute on the aromatic ring. As a consequence, the aromatic ring itself would be too bulky to allow the ligand to bind deeply into the pocket. Therefore, the interactions between ligand IAA61 and the target Na v channel are not as strong when compared with the interactions of ligand IAA69 and the target Na v channel. Further analysis of the interactions between anticonvulsant enaminones and target Na v channel is focused on the hydrogen bonds between three ligands (AAA43, IAA69 and IAA15) and two contact residues, Lys166 and Tyr169. in the interaction maps of IAA69, IAA15 and AAA34, respectively. It is known that more contact residues in the interaction maps could indicate stronger interactions between ligand and target. For the three ligands, the numbers of contact residues in their 2D ligand interactions map are correlated with their Na v channel inhibition activities, as well as, their free energies of binding. Recall from Table 1 , IAA15 is one of the five enaminones that showed strong inhibition of sodium channels in vitro. IAA69 has the lowest free energy of binding as shown in Figure 5 . In contrast, the free energy of binding for ligand AAA34 is not as low as that of ligand IAA69 and ligand IAA15.
Conclusion
Molecular docking studies were carried out on 17 active anticonvulsant enaminones and their interactions with a tetrameric Na v channel. The results suggest that there are four identical pockets in the tetrameric Na v channel that putatively serve as binding sites for the enaminones that result in the inhibition of Na v channels. These four pockets are identical in size and composition and are located in between the four-repeating chains of the Na v channel reported here. In this study, it was found that the binding of enaminones and Na v Channels resulted in the identification of a set of common features and/or mechanism of interactions between the enaminones and the target Na v channel. This was evidenced by the superimposition of docking conformations and by analysis of free energies of binding. The results revealed that all ligand enaminones interacted with contact residues in a given pocket in a similar pattern or mechanism, which was demonstrated by the distribution of alpha spheres and formations of hydro-gen bonds with two important residues in the active binding sites. To our knowledge, this is the first structure-based 3D QSAR study on the inhibition of sodium channels by anticonvulsant enaminones. The common features or mechanism of interactions between anticonvulsant enaminones and target Na v channels discovered, correlate well with the 3D QSAR model generated by using ligand-based CoMFA and CoMSIA analysis. The discovery of putative binding sites and common features or mechanism of interactions between anticonvulsant enaminones and target Na v channels provide a basis for further characterization of pharmacophores and ligand-target binding complexes, which will allow one to design more potent and effective anticonvulsant drugs. Studies such as this will lead to better analysis and selective enhancement of drug candidates for GABAergic disorders such as epilepsy.
